Research desk · KRSA · Nasdaq
KRSA Stock
SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.
CYCLERION THERAPEUTICS, INC. · Pharmaceutical Preparations
CYCLERION THERAPEUTICS, INC. financial statements, chart, and peer compare from SEC filings.
CYCLERION THERAPEUTICS, INC. (KRSA) discovers, develops, or markets pharmaceutical products.
- Market cap
- —
- P/E
- —
- Op. margin
- -597.00%
- Profit margin
- -584.81%
- FCF margin
- -3,654.44%
- ROE
- -111.28%
Related Health Care stocks: ANIX stock financials · TSHA stock financials · PVLA stock financials · RLAY stock financials · COGT stock financials
KRSA financial statements
Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.
KRSA stock peer compare
Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.
Focus chart
Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.
KRSA stock peer headlines
Yahoo Finance RSS for KRSA and the names in Compare.
| Ticker | Date | Headline |
|---|---|---|
| Loading headlines… | ||
KRSA stock price chart
Overlays follow the Compare table.
KRSA stock — research snapshot
Screen strengths and watchouts for KRSA stock from the latest Misprise snapshot.
Strengths
- Debt/equity 0.69 — leverage looks manageable.
Watchouts
- ROA -81.7% — muted asset returns.
- ROE -111.3% — soft equity returns.
- Operating margin -597.0% — thin operating cushion.
- Negative profit margin — earnings quality needs scrutiny.
- Negative FCF margin — cash generation is under pressure.
- Rev CAGR 5Y -2.0%
- Rev CAGR 3Y 91.1%
- EPS CAGR 5Y —
- EPS CAGR 3Y -62.0%
- FCF CAGR 5Y -46.3%
- FCF CAGR 3Y -56.6%
KRSA stock FAQs
Short answers for KRSA stock — statements, sector, and how this page is meant to be used.
What is KRSA stock?
CYCLERION THERAPEUTICS, INC. (KRSA) discovers, develops, or markets pharmaceutical products. KRSA stock sits in Health Care (Pharmaceutical Preparations), listed on Nasdaq.
Where can I find CYCLERION THERAPEUTICS, INC. financial statements?
CYCLERION THERAPEUTICS, INC. financial statements — income statement, balance sheet, and cash flow — are on this KRSA stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.
What happened to KRSA stock?
This page is a research snapshot of CYCLERION THERAPEUTICS, INC. (KRSA) from the latest SEC filings in the Misprise database as of TTM. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.
Does this page show the KRSA stock price?
The live chart on this KRSA stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.
What sector is KRSA stock in?
CYCLERION THERAPEUTICS, INC. is classified in Pharmaceutical Preparations, inside the Health Care sector, and trades on Nasdaq. This page is a research snapshot, not a full company profile.
How do I read KRSA financial statements?
Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.
Where does the KRSA statement data come from?
Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.
Where can I find the KRSA income statement, balance sheet, and cash flow?
On this KRSA stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.
What is the Misprise Score for KRSA stock?
KRSA stock currently scores 0/100 (Watch / incomplete (<60)). CYCLERION THERAPEUTICS, INC. scores weaker or incomplete on durable growth/quality inputs — leverage, coverage, and recent results deserve extra scrutiny. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.
How is the KRSA comparison winner decided?
Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.
What is the Anomaly Score on this KRSA page?
Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.
What does the green grant dot mean on KRSA stock?
A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.
Is KRSA stock a buy?
No recommendation either way. This KRSA stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell CYCLERION THERAPEUTICS, INC..